Villarta, Bb Girl .

HRN: 21-83-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/03/2022
09/08/2022
İVT
25mg
Od
Thickly Msaf
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: